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Newcastle disease (ND) is a highly contagious disease. The present paper deals with 
classification of ND virus (NDV), clinical signs and pathology, virus strain 
classification and molecular backgrounds for the pathogenicity. Major emphasis is 
reviewing immunity and vaccination. Clinical forms of the disease vary depending on 
many factors, but mainly on the virulence of Newcastle disease virus (NDV) strains. 
Virulent strains are considered List A pathogens by the 'Office International des 
Epizooties' (OIE). The virulence has been traditionally determined using in vivo 
pathogenicity tests to distinguish between highly, moderately and low virulent 
isolates. More recently, molecular biological techniques like polymerase chain 
reaction and sequencing have been described to differentiate virulent from non- 
virulent strains. 
The systemic and mucosal immune systems are considered to function more or less 
independently. Systemic antibodies are essential elements in protection against ND, 
whereas the local antibodies limit multiplication of NDV at the site of entry. 
Cytotoxic T lymphocytes specific against NDV have been detected in the spleen of 
vaccinated birds, however, their contribution to protection remains to be elucidated. 
An increase of the number of various leukocyte subsets was noticed in the respiratory 
tract and the Harderian gland (HG), which favours involvement of local cellular 
immunity in the defence against NDV infection. It is tempting to speculate that the 
local lymphoid infiltrates are involved in first defence and that cytolytic cells clear 
virus by directly lysing infected target cells at the site of NDV inoculation. Secondly, 
various cell types, mainly T-lymphocytes and macrophages, may be equipped to 
produce a range of cytokines with antiviral activity and cytokines that stimulate B- 
lymphocytes to proliferate and differentiate into antibody-forming cells responsible 
for the local antibody production against NDV. 
*Corresponding author: e-mail: g.kochOid.dlo.nl 
0 World's Poultry Science Association 2003 
World's Poultry Science Journal, Vol. 59, June 2003 
Received for  publication August 31, 2001 
Accepted for  publication February 5, 2002 185 
NDV Vaccination and immunity: S.O. Al-Gurib et al. 
Vaccination using inactivated virus induces mainly systemic immunity and usually 
protects birds from disease caused by virulent NDV strains. Mucosal vaccination 
would be more attractive, as it induces in addition to systemic immunity a local IgM, 
IgA, and IgG, response as well as a mucosal cellular immune response. These local 
responses contribute to protection against NDV infection of the respiratory tract 
mucosa, which is the first target tissue of infection with this virus. 
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Introduction 
NDV is the causative agent of pseudofowl pest, a devastating disease of poultry. NDV has 
a wide host range and has been reported in most orders of birds. Isolation of a virulent 
strain requires reporting to the “Office International des Epizooties” (OIE, 1996). During 
the last decade, knowledge of the immunobiology of NDV has rapidly increased. New 
data are derived from applications of the whole arsenal of modern technology including 
gene technology, monoclonal antibodies, and synthetic peptides. Although many reagents 
have been developed in the last decades to study the immunity in poultry (reviewed in 
Jeurissen et al., 2000a), these have not been used in depth to study the mechanisms that are 
effective in protection against ND. In the present paper, a review is given of ND. Clinical 
signs and pathology are outlined and the classification of the viruses causing it and the 
molecular bases for pathogenicity are discussed. The diagnosis and definitions of the 
disease are described. Particular emphasis is given on the immunological events that occur 
during infection or vaccination. 
Classification and proteins of NDV 
ND is caused by avian paramyxovirus serotype 1 (APMV-1) viruses, which together with 
viruses of the other eight APMV serotypes (APMV-2 to APMV-9), have been recently 
placed in the genus Avulavirus, sub-family Paramyxovirinae, family Paramyxoviridue. 
This taxonomy was adopted after the complete sequence of the NDV genome was 
presented (De Leeuw and Peeters, 1999) showing that NDV is not a member of the genus 
Rubulavirus. The virus families Paramyxo-, Rhabdo-, F i b ,  and Borneviridae form the 
order Mononegavirales. All viruses within this order have a helical symmetry of the 
nucleocapsid and a non-segmented, single-stranded, and negative sense ribonucleic acid 
genome. NDV encodes at least six major proteins (Figure I) that comprise the 
nucleoprotein (NP), phosphoprotein (P), matrix (M), fusion (F), hemagglutinin- 
neuraminidase (HN) protein and a RNA dependent RNA polymerase (L) (Chambers et al., 
1986; Wilde et ul., 1986). The V protein is synthesised after RNA-editing of the P gene. 
The M protein forms a linkage between the glycoproteins in the virus envelope and the 
nucleoprotein in the nucleocapsid, thus stabilising the virus structure. Two proteins, the 
HN and F protein, form projections on the viral envelope. The HN protein is involved in 
the attachment of the virion to sialic acid-containing receptors on target cells. 
Neuraminidase-activity of the HN mediates cleavage of sialic acid from viral receptors at 
the cell surface enabling virus release from the infected cell. In addition, HN promotes 
fusion activity, since expression of both HN and F is required for syncytia formation 
(Alexander, 1997). The functional F protein induces fusion of the viral and target cell 
membranes and is also responsible for induction of fusion between host cells. This enables 
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the viral transcription unit, consisting of the nucleocapsid and two other proteins, the P and 
L proteins, to enter the cytosol of the host cell (Samson, 1988). Therefore, the HN and F 
glycoproteins are essential for virus infectivity and are ideal targets to prevent infection by 
protective immunity (Meulemans et al., 1987; Nagy et al., 1991; Reynolds and Maraqa, 
2000a). 
HN\ 
Figure 1 A schematic representation of ND virion. 
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Clinical signs and pathology 
The clinical signs reported in birds infected with NDV vary widely but mainly depend on 
virulence of the virus. Other factors determine the outcome of the disease such as the host 
species, age, immune status, infection with other organisms and environmental stress 
(Cheville et al., 1972b; Lancaster, 1981; Campbell, 1986). In some circumstances, with 
extremely virulent viruses the disease may result in sudden death (Cheville et ul., 1972b; 
Brown et al., 1999a). 
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Strains of NDV are distinguished into five pathotypes (Beard and Hanson, 1984): 
1. velogenic viruses (vvND): responsible for disease characterised by acute lethal 
infection showing frequently haemorrhagic lesions of the digestive tract of dead 
birds; 
2. neurotropic velogenic viruses (nvND): causing disease characterised by acute 
neurological signs and often-high mortality which follows respiratory distress; 
3. mesogenic viruses: moderate respiratory disease often seen with high mortality only 
in young birds; 
4. lentogenic viruses: causing mild infections of the respiratory tract; 
5.  asymptomatic enteric viruses: mainly gut infections causing no apparent disease. 
Although these classifications are useful for descriptive purposes, some overlap does 
occur even in experimental infection of specific-pathogen-free (SPF) chickens (Cheville 
et al., 3972b; Alexander and Allan, 1974) and some strains are difficult to place. In 
addition, in the field, aggravating factors such as concurrent infections, and immune 
suppression may result in clinical signs induced by milder strains to resemble those of 
more virulent strains. 
Generally, ND may involve signs of depression, diarrhoea, prostration, oedema of the 
head and wattles. In the vvND, clinical signs often begin with listlessness, increased 
respiration ending with death. Diarrhoea is frequently seen. Surviving birds may develop 
nervous signs such as muscular tremors, paralysis and torticollis (Cheville et al., 1972b; 
McFerran and McCracken, 1988; Bhaiyat et ul., 1994). In nvND, the clinical signs are 
marked by severe respiratory disease shortly followed by neurological signs. With all 
pathotypes of ND, egg production falls dramatically sometimes leading to complete 
cessation of egg laying and death. Virulent ND strains may replicate in vaccinated birds, 
but the clinical signs will be greatly diminished depending on the antibody level (Allan e,t 
al., 1978; Hamid et al., 1990). 
No gross lesions can be considered pathognomonic for any form of ND as is with the 
clinical signs (Cheville et al., 1972b; McFerran and McCracken, 1988; Ojok and Brown, 
1996; Brown et al., 1999). Gross lesions vary depending on virus strain and may also be 
absent. Cadavers of birds that died because of virulent ND, usually have a dehydrated 
appearance. VvNDVs typically cause haemorrhagic lesions of the intestinal tract. Thes'e 
lesions are often particularly prominent in the proventriculus, small intestine and caeca. 
These organs are markedly haemorrhagic which apparently results from necrosis of the 
intestinal wall or lymphoid tissues, such as caecal tonsils (Alexander, 1997). Little 
evidence is found of gross lesions in the central nervous system even in birds showing 
neurological signs prior to death. Gross pathological lesions are usually present in the 
respiratory tract when clinical signs indicate involvement. They consist predominantly of 
haemorrhagic lesions and congestion of the trachea; in addition air sacculitis may be 
evident (Kotani et al., 1987; Hamid et al., 1990). Egg peritonitis is often seen in laying 
hens infected with virulent NDV. 
Microscopic lesions are not regarded as having any diagnostic meaning and can be 
greatly affected by the same parameters as the clinical signs and gross lesions. Generally, 
in most tissues and organs involved, the lesions include hyperaemia, necrosis, cellular 
infiltration, and oedema (Kotani et al., 1987; Hamid et a/.,  1990). Lesions in the central 
nervous system are characterized by nonpurulent encephalomyelitis (Bhaiyat et al., 1994). 
NDV strain classification and molecular basis for the pathogenicity 
Generally, the term strain is applied to describe a well-identified isolate of the virus. 
Pathogenicity tests are useful to determine the virulence of virus strains. Originally strains 
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of NDV were differentiated according to the mean death time of chicken embryos after 
infection. Later differentiation was based on in vivo tests using disease or death 
developing in infected birds as indicator. Different infection routes were used in these 
tests: the intracerebral route in one-day-old chickens to determine the intracerebral 
pathogenicity index (ICPI) and the intravenous route in 6-week-old chickens for the 
intravenous pathogenicity index (IVPI). These indices were calculated according to the 
severity of disease symptoms. The IVPI test is particularly useful for classifying 
moderately and highly virulent NDV isolates, but tends not to show distinction between 
some mesogenic viruses and lentogenic virus. In the ICPI test the mean score per bird per 
24 h observation over 8 days is calculated (Kouwenhoven, 1993; Alexander, 1995). 
Generally, lentogenic viruses give indices of up to 0.6, asymptomatic enteric viruses 
usually slightly lower indices, mesogenic viruses usually around 1.4 and velogenic viruses 
between 1.7 and 2.0. In the European Union (EEC), NDV isolates with an ICPT score 
larger than 0.7 are considered virulent. 
Monoclonal antibodies (MAbs) may detect variation in antigenicity such as single 
amino acid changes of epitopes to which the antibodies are directed. MAbs raised against 
various strains of NDV have been applied in epidemiological studies (Alexander et al., 
1997). Panels of MAbs were used to place strains and isolates of NDV into groups. 
Isolates in the same MAb group shared biological and epizootiological properties. The 
analyses showed that the viruses tend to stay reasonably well preserved during an outbreak 
or epizootics, allowing for suppositions to be made about the origin, spread, and diagnosis. 
Moreover, MAbs have been used to distinguish between common vaccine strains, 
Hitchner B1 and La Sota (Meulemans et al., 1986; Erdei et al., 1987) and they can 
separate vaccine virus from epizootic virus in a given area (Srinivasappa et al., 1986). 
The pathogenicity of NDV largely depends on cleavage of a precursor fusion 
glycoprotein, F, into the subunit proteins F, and F,. It forms a major molecular base for the 
virus particles to be infectious (Glickman et al., 1988; LC Long et a/., 1988; Rott and 
Klenk, 1988). The cleavage is mediated by host cell proteases (Nagai et a/., 1976; Gotoh 
et a/.,  1992). The significance of F, cleavage is simply demonstrated by the inability of 
lentogenic strains to produce plaques in cell culture systems, in the absence of trypsin 
(Rott, 1979; Seal eta/. ,  2000). 
Collins et a/. (1 993) compared the deduced amino acid sequences at the cleavage site of 
the F,, precursor to classify NDV pathotypes. Viruses that were virulent for chickens i.e. 
with high ICPI values had the sequence "2Arg/Lys-Arg-Glu/Lys-Arg/Lys-Arg"b at the C- 
terminus of the F2 protein and phenylalanine at residue 11 7, the N-terminus of the F, 
protein. Viruses of low virulence had the sequence motive of *12Gly/Glu-Lys/Arg-Glu- 
Gly/Glu-Arg'I" and leucine at residue 11 7 in the same region. Thus, for the virus to be 
virulent a double pair of basic amino acids is apparently required at residues 112 and 113 
and at residues 115 and 1 16, plus a phenylalanine at residue 117. The importance of the 
amino acid sequence around the cleavage site was recently demonstrated more directly 
when a La Sota vaccine virus was engineered by reverse genetics to contain multiple basic 
amino acids. The ICPI rose from 0,0 to I ,4 for the engineered virus containing multiple 
basic amino acids (Peeters et a/.,  1999). Differences in pathogenicity were also recorded 
using 14-day-old chicken embryos. The cloned rescued original La Sota was only detected 
extra-embryonically in the chorioallantoic membrane and the lung of the embryo, whereas 
the newly molecular-engineered La Sota was found also in the internal organs, e.g. heart 
and spleen (Al-Garib et al., 2002 and manuscript in preparation). These phenotypic 
differences are probably also related to the expression of host proteases in cells. The 
findings that virulent strains of NDV replicate in systemic organs, whereas lentogenic 
strains of NDV are only detected in the respiratory tract (Ojok and Brown, 1996; Brown 
et al., 1999; Al-Garib et al., unpublished results) are in line with this assumption. 
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In some lentogenic viruses the sequence at the cleavage site is not stable. Sequence 
analyses of virus isolates of a recent Australian outbreak suggested that the original 
lentogenic Peat’s Ridge strain evolved into virulent viruses containing multiple basic 
amino acids (Westbury, 2001). Moreover some but not all lentogenic NDV isolates from 
waterfowl can evolve into velogenic virus in vivo by acquiring multiple basic amino acids 
and a phenylalanine around the cleavage site after passaging in chickens. However, the 
fact that not all waterfowl isolates could evolve into velogenic viruses suggests that other 
factors than the sequence around the cleavage site may have a role in the pathogenicity 
(Shengqing el al., 2002). 
Origin, host-range and transmission of NDV 
ND as a highly pathogenic disease of poultry was initially reported in 1926 in Southeast 
Asia (Alexander, 1997). Later, NDV became distributed world-wide and was reported to 
non-reproductively infect animals other than birds, ranging from reptiles to humans. All 
bird species are probably susceptible to the infection but the disease may vary enormously 
from one avian species to another with any given virus strain (Kaleta and Baldauf, 1988). 
Various authors have discussed how NDV may be introduced into a country or region 
and subsequently spreads from flock to flock (Lancaster and Alexander, 1975; Alexander, 
1988; Kouwenhoven, 1993; Alexander, 2000). They concluded that transmission of 
infection might take place by either inhalation or ingestion. It is tempting to speculate that 
fine aerosols or large droplets full of virus particles may be inhaled and stick to the 
I ~ U C O U S  membranes resulting in infection of susceptible birds. Because a large amount of 
virus is excreted via droppings during the course of infection, ingestion of faeces results 
also in infection. Therefore, the main modes by which virus spreads are movement of live 
birds, movement of people and equipment, movement of poultry products, contaminated 
poultry food or water, airborne spread, vaccines and non-avian hosts. 
Diagnosis and definition of ND 
Avian paramyxovirus- 1 infections are usually diagnosed by virus isolation. Serology can 
be used only in non-vaccinating countries (OIE, 1996). NDV can most easily be isolated 
from tissue samples or faecal or tracheal swabs from infected birds by inoculation of 
eight- to ten-day-old embryonated chicken eggs via the allantoic cavity (Alexander, 1997). 
Confirmation of the virus as belonging to the APMV-1 serotype, can be performed by 
haemagglutination inhibition (HI) tests using a panel of specific antisera. 
The large difference in virulence resulting in a range of clinical symptoms signifies that 
an accurate definition of what constitutes ND, is essential for the purposes of diagnosis 
and control programs (policies and vaccination). ND is defined as an infection of birds 
caused by a virus of avian Paramyxovirus serotype 1 (APMV-1) that fulfils one of the 
subsequent criteria for virulence (OIE, 2000): the virus has an ICPI in day-old chicks 
(Gallus gallus) of 0.7 or larger or, alternatively, the virus has multiple basic amino acids at 
the C-terminus of the F, protein and phenylalanin at residue 117 at the N-terminus of the 
F, protein. The term multiple basic amino acids refers to at least three arginine or lysine 
residues between residues 112 to 116. Failure to demonstrate the characteristic pattern of 
amino acid residues as described above would require characterisation of the isolated virus 
by an ICPI test. 
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Immunity against NDV 
The respiratory tract is the main site of entry of NDV. Local immediate immune 
mechanisms therefore form a first line of defence against infection. Compared to 
mammals, lavage fluids of the respiratory system of chickens contain a low steady state 
number of macrophages and heterophils that for the sake of simplicity are further 
indicated as avian respiratory phagocytes. The difference is particular striking because the 
ratio between the respiratory epithelium and the volume of lungs is much larger in birds 
than in mammals. Birds seem to compensate for the assumed deficiency through a rapid 
influx of respiratory phagocytes against invading pathogens. For ND, the influx of 
leukocytes in the respiratory tract lumen has not been studied, but evidence was obtained 
that NDV could have a negative effect on these cells. Avian respiratory phagocytes in ND- 
vaccinated birds have a lower phagocytic and bactericidal activity which might explain 
the occurrence in the field of vaccination reactions that are caused by concurrent bacterial 
infections such as with Mycoplasma spp (Toth et al., 2000). 
At first, NDV targets epithelial cells lining the respiratory tract and depending on the 
virus strain, also of the gastrointestinal tract (Cheville et al., 1972a). In vitro, NDV induces 
the production of interferon type I and type I1 in fibroblasts, since culture medium of 
infected fibroblast showed both antiviral activity and induced no production in chicken 
macrophages (Heller et al., 1997). Moreover, lentogenic NDV induced expression of 
mRNA transcripts in primary chicken macrophages ( Sick et al., 1998) and transcripts 
were detected by in situ hybridisation using riboprobes in formalin fixed tissue sections of 
lymphoid tissues and spleens of chickens infected with velogenic NDV (Brown et al., 
1999b). It was already known that NDV stimulates the production of interferon a and p by 
murine macrophages (Hoss et al., 1989) and of interferon-y by murine T cells. Whether 
interferon production interferes with NDV replication and spreading in vivo has, however, 
not been investigated. 
When NDV successfully overcomes the innate response, it probably triggers both an 
antibody and cellular T-cell response, as these responses are common in viral infections 
(Zinkernagel et al., 1994). Although our knowledge of avian immunology has progressed 
rapidly in the last decades, very little is known about the efficacy of the cellular immune 
response against NDV. Leukocyte infiltrates do occur at sites of viral replication (Cheville 
et ul., 1972b; Kotani et al., 1987) such as the respiratory tract and the Harderian gland 
(HG) (Russell et al., 1997). These infiltrates comprise all elements required for the 
induction of a cellular immune response like macrophages and CD4 and CD8 T- 
lymphocytes (Russell et al., 1997; Al-Garib et al., manuscripts in preparation). Most of the 
infiltrated lymphocytes in the tracheal mucosa and the HG express y6 or ap 1 T cell 
receptors (TCR1) and might be activated since many leukocytes within the infiltrates 
express MHC class I1 epitopes. Although the HG of normal chickens already contains T- 
and B-lymphocytes their numbers increased 2-3 fold after vaccination with lentogenic or 
mesogenic virus strains (Russell et al., 1997; Al-Garib et al., manuscript in preparation). 
We can only speculate on the cytotoxic and/or antiviral activity of the CD8' cells. 
Cytotoxic T-lymphocytes were detected in the spleen of vaccinated chickens after in vitro 
re-stimulation (Cannon and Russell, 1986) or ex-vivo in chickens vaccinated twice or 
vaccinated and challenged with virulent virus (Jeurissen et al., 2002a). In the latter 
experiments the cytotoxic activity was shown to be MHC-class I restricted. 
The dogma is that CD4' T cells are activated by antigen only after phagocytosis and 
processing by antigen-presenting cells. Activated CD4' T-cells release cytokines that: (1) 
can impair or kill target cells: or (2) recruit and regulate non-specific effector cells, such 
as macrophages which then kill the targets (Kaiser, 1996). In addition, CD4' T cells 
activate B-cells leading to proliferation and differentiation into antibody producing cells 
and formation of memory B-cells. 
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Antibodies constitute an essential component of the protection against NDV and are 
important for the clearance and neutralisation of pathogen in principle in two ways: ( I )  by 
binding to infected cells and thereby reducing the production of progeny virus, and (2) by 
binding to released progeny virus and thereby inhibiting its spread. Antibodies capable of 
protecting the host can be measured in virus neutralisation (VN) tests. However, since the 
V N  response appears to parallel the haemagglutination inhibition (HI) response, mainly 
the HI test is used to assess protection, especially after vaccination (Allan et al., 1978). 
Neutralising antibodies are directed against both the HN and F proteins. Chickens 
passively immunised with anti-sera against the nucleo- and phosphoproteins or against the 
matrix protein did develop antibody titres detectable in an ELISA but not in a 
neutralisation test and the birds developed clinical signs after a ND challenge infection 
(Reynolds and Maraqa, 2000a). 
Using an ELISA, the kinetics and Ig-class distribution of an antibody response against 
NDV was determined (Al-Garib et al., 2003a). IgG and IgM antibody was predominantly 
detected in serum. After primary infection, IgM was detected as early as day 4 after 
vaccination, followed by IgA and IgC from day 7 after infection onwards. Antibodies in 
serum will confine infection to the respiratory mucosa. In contrast, secretory antibodies 
probably function to prevent or reduce virus replication in the epithelium. Antibodies were 
detected in secretions of the upper respiratory tract and intestinal tract of chickens at about 
the same time humoral antibodies could be first detected in blood. In secretions, all three 
Ig-classes were recognised after local infection with live virus, but only IgM and IgG after 
systemic immunisation with inactivated NDV (Al-Carib et ul., 2003a). 
After parental immunisation, the respiratory tract is less protected and viral replication 
at this site is not prevented (Parry and Aitken, 1977; Holmes, 1979). Using this route no 
IgA-response was detected using the ELISA (Al-Garib et al., 2003a). In contrast, 
immunity after local vaccination will reduce replication at this site, giving the immune 
system more time to mount secondary responses (Parry and Aitken, 1977; Holmes, 1979). 
Based on data obtained from mammals, it was suggested that the systemic and mucosal 
immune systems function more or less independently. This seems to be also true for 
chickens. Thus, local inoculation with live NDV stimulates local production of antibodies 
in  the upper respiratory tract and systemic production in the spleen (Parry and Aitken, 
1977; Ewert et al., 1979; Russell and Koch, 1993). In contrast, parental immunisation with 
inactivated NDV leads to production in the spleen and no or little local production 
resulting in antibodies mainly in the serum and no or little antibodies in secreta (Beard and 
Easterday, 1967a; Parry and Aitken, 1977; Holmes, 1979; Russell and Koch, 1993). In 
conclusion, mucosal ND vaccination induces responses mainly comprising IgA and less 
IgM and IgG (Al-Carib et al., 2003a), which would prevent re-infection and thus provide 
a better, more durable protection (Parry and Aitken, 1977; Holmes, 1979). 
The mechanism of protection by secretory antibodies in particular in the chicken is not 
entirely clear. In mammals, IgM antibodies are highly efficient in aggregating virions and 
in mediating lysis of infected cells by complement via the classical pathway. IgG 
antibodies can bind to released virions, promoting phagocytosis by neutrophils and 
macrophages via the Fc receptor, and mediating cellular lysis by complement via the 
classical pathway. IgA antibodies function mainly by binding to released virions (Daniele, 
1990) thereby preventing infection of the epithelial cells. Mammal IgA can activate 
complement via the alternate pathway allowing phagocytosis by alveolar macrophages. It 
is unknown whether these functional properties can be extrapolated to IgA of the chicken. 
Secretory immunoglubulins, however, were shown to have neutralising activity in vitro 
(Ewert et al., 1977; Parry and Aitken, 1977; Caporale et al., 1978). 
There is a need to correlate various quantitative and qualitative predictors to build a 
comprehensive picture of the biology of the antibody response. Immunocytochemical 
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methods can be used to visualise plasmablasts and plasma cells in situ, based on the 
specific antigen-binding capacity of the antibody they contain (Jeurissen et al., 2000b). 
Therefore, a new in situ technique to detect anti-NDV producing cells in tissue sections 
was developed (Al-Garib et al., 2003b). Antibody-producing cells were stained in spleen 
in large numbers at 7 days after infection with a mesogenic strain of NDV. These cells 
produced mainly IgM and IgG. Most of the NDV antibody-producing cells located in the 
Harderian gland and respiratory tract mucosa however, produced IgA (Russell and Koch, 
1993; Al-Garib et al., unpublished results). The finding correlates well with high IgM and 
IgA responses against NDV that were revealed by ELISA in trachea washes and bile of 
locally infected birds (Al-Garib et al., 2003b). 
In addition to antibodies, systemic and local cellular immune responses may also 
contribute to protection against infection. The systemic cellular response is detectable as 
early as 2-3 days after live NDV vaccine infection using leukocyte migration inhibition 
test (Ghumman and Bankowski, 1975; Timms and Alexander, 1977). The systemic cell 
mediated immunity has been investigated by secondary in vitro stimulation of spleen 
lymphocytes (Cannon and Russell, 1986). It was found that these cells were capable of 
rapidly lysing NDV-labelled target cells as measured in a 51Cr-release assay. From this, it 
was concluded that spleen cells comprise a cytotoxic effector cell population. The effector 
cells are probably T-cells. Recently, a new detection system was described (Jeurissen et 
ul., 2000a) for cytotoxic T lymphocyte responses against Newcastle disease virus (NDV). 
Using the system, the authors demonstrated cytotoxic T lymphocytes in spleens of 
chickens that were vaccinated twice with live ND vaccines or that were vaccinated and 
challenged with virulent NDV. 
It is difficult to assess the contribution of cellular (T-cell) and of humoral (B-cell) 
responses to protection. One approach to elucidate their respective role has been to destroy 
one component of the immune system leaving the other component intact. Thus the bursa 
was destroyed either surgically or chemically to deplete cells of B-cell lineage, or the 
thymus was removed surgically to deplete cells of the T-cell lineage. The interpretation of 
such experiments is difficult, because (1) bursa depletion does not always lead to 
agammaglobulinaemic birds, ( 2 )  bursectomy has an effect on thymus development 
(Zucker et al., 1973), although this latter effect seems to have no effect on T-cell function 
(Vainio and Toivanen, 1987), (3) thymectomy will not lead to complete T cell deficiency 
and on the other hand, it will also deplete helper T cells that are required for an effective 
B cell response, and (4) chemical depletion of T cell subpopulation also has an effect on 
the number of B cells (Russell et al., 1997). Bursectomized chickens that were 
additionally irradiated or treated with anti-bursa cell antiserum developed no antibodies 
against NDV or low levels of it after vaccination, and they died after an intramuscular 
challenge with virulent ND virus. In contrast, thymectomised, irradiated chickens 
developed antibodies and were resistant to challenge (Cheville and Beard, 1972; Marino 
and Hanson, 1986; Perey and Dent, 1975). Moreover, the delayed type hypersensitivity of 
thymectomised birds was only diminished but not absent after local injection of NDV in 
the wattle and thus from such experiments one can not firmly conclude that T cell 
responses do not contribute to protection. Irradiation seems to be crucial, because in later 
experiments, bursectomy without irradiation resulted only in selective deficiency for IgA 
(Ewert and Eidson, 1977). All bursectomised chickens remained healthy after challenge 
with virulent NDV suggesting that IgA is not essential for the development of immunity 
but that locally produced IgM and transuded serum IgG antibodies protect the trachea 
mucosa in the absence of IgA. Since antibody levels of sham-bursectomised and 
bursectoinised birds were similar after vaccination, the results can not be used to conclude 
on a possible role of cell mediated immunity in protection. Of chickens bursectomised in 
ovo and treated twice with anti-chicken bursa1 cell antiserum 44% had no detectable 
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immunoglobulin in serum, but nevertheless 66% of those chickens produced antibodies at 
levels that may well have protected the birds against mortality on challenge infection. 
Thus, although the bursectomised chickens showed equal or better in vitvo blastogenic 
responses against PHA mitogen and NDV antigen, this does not univocally prove the 
importance of the cell-mediated response (Marino and Hanson, 1987). 
Drug treatments were used as another strategy to deplete T-cells or B-cells. 
Cyclophosphamide treatment in ovo was used as an immunosuppressive agent to deplete 
B-cells and thus to repress the humoral response leaving the cellular response intact. Birds 
that hatched form treated eggs and that survived a challenge infection, all had antibodies 
detectable in the HI and VN tests. Birds without antibodies but with positive blastogenic 
response against NDV were not protected (Reynolds and Maraqa, 2000b). In contrast, in 
another experiment birds that were treated with cyclophosphamide after hatch did not 
produce antibodies upon intranasal or subcutaneous vaccination. The intranasally but not 
the subcutaneously vaccinated birds were resistant against an intranasal challenge with a 
velogenic NDV. Antibodies were detectable in the trachea washings of the resistant birds 
demonstrating the importance of local immunity (Lam and Haq, 1987). Thus antibodies 
play a key role in protection against clinical signs. The importance of antibodies probably 
is best demonstrated by the resistance that is acquired after intravenous injection of a large 
amount of ND immune sera to infection with virulent NDV via the intramuscular route 
(Beard and Easterday, 1967b; Malkinson and Small, 1977; Reynolds and Maraqa, 2000b). 
The tracheas of the same birds that received passive antibodies intravenously, however, 
were not protected against infection demonstrating the importance of the local antibody 
response. In particular antibodies directed against the haemagglutinin and fusion proteins 
mediated protection, whereas antibodies against the internal viral proteins did not 
(Reynolds and Maraqa, 2000b). Treatment of cyclosporine A reduced the blastogenic 
response and the number of most T cell subpopulations (i.e. CD4 and CD8) significantly 
and retarded but did not diminish the antibody response by 1 to 7 days (Russell et al., 
1997). Because the antibody response was retarded but not diminished, the slower 
clearance of Hitchner B1 from the HG conjunctiva and trachea that was observed cannot 
simply be attributed to a diminished T-cell function. 
A key role for antibodies in protection against ND appears from all results found 
published and mentioned above. Antibodies might be so effective, because the NDV 
replicates rapidly enabling large amounts of the infectious virus to be released from 
infected cells. With such kinetics, the cellular immune response may simply be too slow 
to significantly change the peak titre in the infected host, whereas antibodies within the 
tissue neutralise virus preventing its further spread. Nevertheless, there might still be a 
role for the local cell-mediated immunity since after systemic vaccination of birds virus 
did not replicate or shed from the trachea after local challenge (Reynolds and Maraqa, 
2000b). A role of the cellular immunity can also be concluded from the interaction 
between chicken infectious anaemia virus (CIAV) and live NDV vaccination. Vaccination 
reactions were greatly exacerbated when chicks were infected with CIAV and vaccinated 
with NDV at one day old or infected with CIAV at one day old and vaccinated with NDV 
at day 10. The CIAV infection did not effect the level of hemagglutination inhibiting 
antibodies that were induced by the vaccination with NDV. CIAV is known to suppress the 
production of interferon-y, IL- 1 and IL-2, to decrease mitogen responsiveness of spleen 
cells (Adair et al., 1991; McConell et al., 1993a) and to impair macrophage function 
(McConell et al., 1993b). Moreover, CIAV infection interferes with the cytotoxic T 
lymphocyte responses (Markowski-Grimsrud and Schat, 2001). 
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Vaccination against NDV 
Vaccination of commercially reared birds is the only way to reduce disease and thus losses 
resulting from infection. When designing a vaccination programme, consideration should 
be given to the type of vaccine used, the immune and disease statuses of the birds to be 
vaccinated, and the level of protection required in relation to any possibility of infection 
with field virus under local conditions (Allan and Lancaster, 1978). Moreover, when 
vaccination is used to stop transmission it should induce sufficient herd immunity. ND 
vaccines are routinely only tested for their effectiveness to induce clinical protection, 
which does not provide information about the level of transmission, because factors that 
cause clinical signs differ from factors that cause transmission. As discussed earlier, 
clinical signs are caused by virus replication within the chicken for example in visceral 
organs or brain tissue, whereas transmission occurs between chicken via infected 
secretions, direct contact, or via air. Moreover, virus transmission starts well before 
clinical signs become apparent and often occurs subclinically. 
At first vaccination was performed using inactivated infective material, which was 
shown to induce protection in inoculated chickens. Inactivated vaccines however, never 
flourished, not only because of problems in production and standardisation, but also 
because enzootic viruses like the Roakin strain were discovered that only produced mild 
disease and therefore were used to develop live vaccines (Beard and Hanson, 1984; 
Beaudette et al., 1949). Subsequently, viruses of even less virulence were discovered like 
the Hitchner-B, (Hitchner and Johnson, 1948) and La Sota (Goldhaft, 1980) strains. Only 
recently, various recombinant vaccines that can provide protection against ND have been 
developed expressing either the F or HN protein or both (Meulemans et al., 1988; Nagy el 
al., 1991; Nishino etal., 1991). 
Presently, mesogenic live vaccines are advocated only in countries where virulent NDV 
is endemic. Better transmission of mesogenic viruses combined with a higher level of 
induced immunity is of advantage to prevent serious disease particularly in areas with 
backyard poultry (Reeve and Alexander, 1974). In chickens experimentally infected with 
the Roakin strain of NDV, humoral antibody levels were found to be three to five fold 
higher than in La Sota infected birds (Al-Garib et al., 2003a). Unfortunately, the better 
protection is going along with serious vaccination reactions in particular in birds under 8 
weeks of age, in birds that have not been immunised previously, or in immunocompromised 
birds. For these reasons, mesogenic viruses were excluded within the EEC and from the 
concept OIE definition of ND. Also, the safety of mesogenic vaccines should be checked 
even more carefully than of lentogenic strains in view of the recent findings that virulence 
of NDV may increase upon passage in chickens (Shengqing et al., 2002). 
Most live vaccines currently used in most countries are derived from lentogenic field 
strains. Still these strains have variable residual pathogenicity (Borland and Allan, 1980) 
and consequently vaccination reactions are inevitable. Cloning was used to obtain viruses 
with high immunogenicity combined with acceptable vaccination reactions. Recently, 
“asymptomatic enteric” strains became popular because these strains do not cause 
vaccination reaction at least not in the respiratory tract. The Australian V4 and Ulster 
strains of NDV belong to this latter category. 
Inactivated vaccines generally induce extremely high levels of protective antibodies that 
persist for a long time and therefore are applied for revaccination for instance to protect 
laying hens during the entire production period. Because inactivated vaccines are more 
laborious to produce and require individual application their use is extremely expensive. 
Effective vaccination requires ideally that all birds in a flock get vaccinated. Since the 
spread of lentogenic viruses may be limited, individual application by eye or nose drop is 
preferred to obtain uniformly high levels of protection. Individual application is too 
laborious and therefore is practiced in small flocks only. As a result, mass application 
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using spray or aerosol equipment or via the drinking water is favoured because it is cheap 
and convenient. Moreover, this application method triggers local cellular and humoral 
immunity in the respiratory tract preventing infection of mucosal surfaces or reducing 
virus replication at this site. As a result virus invasion to systemic tissues is blocked. 
Difference in effect of spray and aerosol are caused by the size of the droplets. Coarse 
droplets are short-lived in air, whereas fine droplets i.e. aerosols are long-lived. As a 
consequence the type of equipment, simple spray apparatus vs. atomiser, nozzle size, and 
air pressure in the apparatus are important factors of effectiveness, since these determine 
droplet size. Moreover, coarse droplets will carry over a short distance and birds have to 
be hit directly, which is not required for an atomiser. On the other hand aerosols compared 
to coarse droplets penetrate deeper into the (lower) respiratory tract and as a result cause 
more severe vaccination reactions. Aerosol application is therefore usually limited to 
secondary vaccination. Drinking water vaccination can also be used but gives varying 
results due to the variations in water intake between birds (Kouwenhoven, (1993). 
Three decades ago, the in ovo route of vaccination has been introduced as an effective 
route of vaccine administration. Until recently, this route could not be used for NDV 
vaccine because it will kill or weaken the embryo. The problem was tackled by treating 
virus with an alkylating agent, ethylmethane sulfonate, to cripple the virus (Ahmad and 
Sharma, 1992) or by preparing complexes of virus and neutralizing antibodies (Haddad et 
al., 2002). Reverse genetics can also be used to produce ND vaccines with reduced 
pathogenicity for chicken embryos. One such virus expresses low levels of the V protein, 
exhibits impaired replication, but still induces protective antibody levels in hatched 
chickens (Mebatsion et al., 2001). 
Results of vaccination studies cannot be compared easily because of the many variables 
and the differences in methods and materials used. Thus the ideal vaccination schedule can 
not easily be given. The level of maternal immunity, the type of bird (among others 
broilers vs. layers) and of vaccine, the vaccination equipment, workmanship of the 
applicant, all will affect the outcome of the vaccination. Although one-day-old chicks do 
not respond very well with increased blood levels of antibodies to vaccination either at the 
hatchery or at the farm because of interference by maternal immunity, vaccination is 
beneficial because it induces a local immune response in the respiratory tract and 
vaccinated chicks are protected although less sustainable than after vaccination at an older 
age. Secondary vaccination is thus required and should be applied between I8 and 21 days 
of age, which will boost immunity, in particular, when using aerosol and less attenuated 
vaccines. Such a vaccination scheme was recommended for use in broilers in the 
Netherlands until mid 2001 when the vaccination enforcement was revised. In the field the 
results in broilers were disappointing with mean titre values of 23 well below the mean 
level of 25.2, which was presented by Allan et al., (1 978) as 100% protective. The fear for 
severe vaccination reactions may have been the reason for using spray in stead of aerosol 
and Clone30 vaccines in stead of more virulent vaccines based on uncloned LaSota 
vaccines. In this respect, the in ovo route of vaccination promises to be an attractive 
alternative. Zn ovo application of a antibody-NDV complex vaccine protected 98-100% of 
broilers from 7 days of age during the entire fattening period to an intramuscular challenge 
with velogenic Texas GB (Haddad et ul., 2002). Field experiments using this route are 
underway. 
Conclusions 
Newcastle disease is a highly contagious viral disease of chickens. The clinical outcome of 
the disease varies and is dependent upon several factors, but mainly on the characteristics 
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of the virus. Definition of ND is principally based on the value of the intracerebral 
pathogenicity index and/or the presence or absence of multiple basic amino acids at the 
cleavage site of the F protein. Vaccines have long been available and administered to 
control ND. Locally replicating vaccine strains offer an attractive approach for immune 
interventions by providing an effective and durable immunity. However, continued 
improvements of ND control will require a better understanding of immunological 
mechanisms that are triggered by an immunisation regimen and its effect on virus 
transmission. A major function of the humoral immunity is the protection against clinical 
signs caused by infection with virulent NDV strains, whereas expansion in the numbers of 
various leukocyte subsets at the site of vaccination could be responsible for uptake, 
processing of virus antigen and production of antibodies and antiviral cytokines. Therefore, 
it is interesting to investigate the cells producing cytokines at the site of NDV inoculation. 
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